DePuy Orthopaedics approves $2.475 billion settlement agreement in defective ASR hip implant litigation

In 2013, DePuy Orthopaedics, a subsidiary of Johnson & Johnson, agreed to a $2.475 billion settlement to resolve thousands of claims concerning injuries caused by ASR hip implant components.

DePuy faced more than 10,000 cases in the U.S. related to its ASR XL Acetabular and ASR Hip Resurfacing Systems, which it recalled in August 2010 amid reports of a significantly high failure rate after only five years of use.

Beasley Allen attorney Navan Ward was selected as a member of the Plaintiffs Steering Committee, which was responsible for overseeing the consolidation litigation involving cases against DePuy Orthopaedics regarding their hip implant products liability.

“Many of our clients suffered negative outcomes resulting from their ASR hip implant, including but not limited to premature hip revision surgery(s),” said Ward. “I am pleased that we could resolve this matter for our clients and provide them with the compensatory damages they were owed.”

More than 93,000 people worldwide were affected by the DePuy hip implant recall. Patients experienced pain, swelling, and difficulty walking due to metal-on-metal parts. The ASR implant showed it could loosen the bone and cause metal poisoning.

The settlement was approved by U.S. District Judge David A. Katz in the Northern District of Ohio, overseeing the consolidated litigation, along with the other state court judges where cases were filed.